Keyphrases
Visceral Leishmaniasis
100%
Leishmania Infantum
64%
Trypanosoma Cruzi (T. cruzi)
59%
Leishmania Donovani
47%
IC50 Value
37%
Phosphatidylcholine Liposomes
30%
Preclinical Candidate
30%
Metabolic Profiling
30%
Liver
29%
In Vivo Efficacy
28%
Drug Development
28%
Amastigote
26%
Nanoliposomes
22%
Nitazoxanide
22%
Murals
22%
Nectandra Oppositifolia
22%
Compound 8
22%
Dundee
22%
Guided Synthesis
22%
Sphingosine-1-phosphate Receptor (S1PR)
22%
Intracellular Amastigotes
22%
Efficiency Analysis
22%
Pyridazinone
22%
Suramin
22%
Chagas Disease
22%
Proteasome Inhibition
22%
Xenobiotics
22%
Rapid Assessment
22%
Bioactive Compounds
22%
Infectious Diseases
22%
Leishmania
22%
Relative Fitness
22%
Sertraline
22%
Structure-based Design
22%
Amiodarone
22%
Antiarrhythmic Drugs
22%
Protease Inhibitors
22%
Antitrypanosomal Activity
22%
Drug Metabolism
22%
Mechanism of Action
22%
Multidrug-resistant
22%
Cross-resistance
22%
Drug Discovery
22%
African Trypanosomes
22%
Humanized Models
22%
Spike Glycoprotein
22%
Soft Drugs
22%
Parasite Burden
21%
Spleen
21%
Protocatechuic Acid
15%
Pharmacology, Toxicology and Pharmaceutical Science
Visceral Leishmaniasis
77%
Leishmania
57%
Disease
48%
Proteasome
45%
Phosphatidylserine
45%
Trypanosoma Cruzi
43%
Amastigote
39%
Infection
36%
Liposome
34%
Drug Development
26%
Protocatechuic Acid
22%
Proteasome Inhibitor
22%
Chagas Disease
22%
Topical Agent
22%
Sphingosine 1 Phosphate Receptor
22%
Nitazoxanide
22%
Antitrypanosomal
22%
Drug Discovery
22%
Amiodarone
22%
Antiarrhythmic Agent
22%
Sertraline
22%
Drug Metabolism
22%
Ponesimod
22%
Drug Concentration
22%
Dermatitis
22%
Phenol
22%
EC50
19%
Wild Type Mouse
15%
Parasitosis
13%
Cryo-Electron Microscopy
13%
Mouse Model
13%
Pharmacokinetics
13%
IC50
12%
Tropical Disease
11%
Leishmania infantum
11%
Repurposing
10%
Hamster Model
8%
Efficacy Study
7%
Efficacy Assessment
7%
Mycobacterium Tuberculosis
7%
Phytochemical
7%
Lipophilicity
7%
Ultra High Performance Liquid Chromatography
7%
Pentobarbital
7%
Active Metabolite
7%
Benznidazole
7%
High Performance Liquid Chromatography
7%
Drug-Drug Interaction
7%
Propane
7%
Cytotoxicity
7%
Immunology and Microbiology
Visceral Leishmaniasis
90%
Proteasome
45%
Trypanosoma Cruzi
40%
Leishmania
38%
Amastigote
34%
Leishmania donovani
34%
Infectious Disease
28%
Macrophage
28%
Parasitology
28%
Experimental Model
22%
Xenobiotic
22%
Drug Metabolism
22%
Trypanosoma
22%
Glycoprotein
22%
Cross-Resistance
22%
Wild Type Mouse
22%
Metabolite
22%
EC50
19%
Parasite Load
17%
Pharmacokinetics
17%
Mouse Model
17%
Cell Line
15%
Chagas Disease
13%
Protozoa
13%
Parasitic Disease
12%
Blood Level
11%
Granuloma
11%
Chemokine
11%
Cytokine
11%
Host Cell
11%
Intracellular Parasite
11%
Mycobacterium Tuberculosis
11%
Species Difference
11%
Drug-Drug Interaction
11%
Interleukin 6
11%
Leishmania infantum
11%
Cryo-Electron Microscopy
10%
DNA Barcoding
7%
Drug Resistance
7%
Resistant Cell Line
7%
Illumina Dye Sequencing
7%
Antigenic Variation
7%
Drug Interaction
7%
Trypanosomatid
7%
Innate Immune System
7%
Immune Evasion
7%
CRISPR/Cas9
7%
Null Cell
7%
Kinetoplastida
5%
Mutagenesis
5%